AI assistant
Atara Biotherapeutics, Inc. — Director's Dealing 2018
Mar 19, 2018
34205_dirs_2018-03-19_f8193b37-ed5c-4dce-9676-ad82c18aa5a4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Atara Biotherapeutics, Inc. (ATRA)
CIK: 0001604464
Period of Report: 2018-03-15
Reporting Person: Ciechanover Isaac E. (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-15 | Common Stock | S | 2800 | $41.87 | Disposed | 221278 | Indirect |
| 2018-03-15 | Common Stock | S | 1600 | $42.95 | Disposed | 219678 | Indirect |
| 2018-03-16 | Common Stock | S | 3100 | $41.75 | Disposed | 216578 | Indirect |
| 2018-03-16 | Common Stock | S | 1300 | $42.59 | Disposed | 215278 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 812613 | Direct |
Footnotes
F1: Transaction pursuant to Rule 10b5-1 Plan adopted May 18, 2017.
F2: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $41.55 to $42.10. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F3: Shares are held by the Isaac E. Ciechanover and Allison M. Ciechanover Family Trust dated 8/8/08, of which the Reporting Person is a trustee.
F4: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $42.75 to $43.15. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F5: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $41.20 to $42.15. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
F6: The price in Column 4 is a weighted average sale price. The prices actually received ranged from $42.45 to $43.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.